How The Deal Between Synthetic Genomics, Exxon Fell Part
socalTECH
APRIL 19, 2013
It all looked good at the time: oil company Exxon needed to develop a more earth-friendly way to produce oil, and San Diego startup Synthetic Genomics needed funding to get its technology off the ground. But then, ExxonMobil cut back its original investment--worth up to $600M--in Synthetic Genomics. What happened?
159 
Let's personalize your content